HPM Partners LLC purchased a new position in shares of Teleflex Incorporated (NYSE:TFX) during the 4th quarter, HoldingsChannel reports. The firm purchased 7,380 shares of the medical technology company’s stock, valued at approximately $1,836,000.
Other hedge funds and other institutional investors also recently modified their holdings of the company. American Century Companies Inc. increased its holdings in shares of Teleflex by 24.1% in the 4th quarter. American Century Companies Inc. now owns 1,474,609 shares of the medical technology company’s stock valued at $366,912,000 after acquiring an additional 286,700 shares during the last quarter. Renaissance Technologies LLC increased its holdings in shares of Teleflex by 511.6% in the 4th quarter. Renaissance Technologies LLC now owns 195,700 shares of the medical technology company’s stock valued at $48,694,000 after acquiring an additional 163,700 shares during the last quarter. BlackRock Inc. increased its holdings in shares of Teleflex by 3.4% in the 4th quarter. BlackRock Inc. now owns 4,709,341 shares of the medical technology company’s stock valued at $1,171,779,000 after acquiring an additional 156,527 shares during the last quarter. Rock Springs Capital Management LP purchased a new position in shares of Teleflex in the 4th quarter valued at about $22,829,000. Finally, First Trust Advisors LP increased its holdings in shares of Teleflex by 126.7% in the 4th quarter. First Trust Advisors LP now owns 119,580 shares of the medical technology company’s stock valued at $29,754,000 after acquiring an additional 66,822 shares during the last quarter. Institutional investors own 90.75% of the company’s stock.
Shares of Teleflex Incorporated (NYSE:TFX) opened at $269.26 on Monday. The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.51 and a current ratio of 2.33. The firm has a market capitalization of $12,129.97, a P/E ratio of 32.06, a price-to-earnings-growth ratio of 1.99 and a beta of 1.22. Teleflex Incorporated has a 1 year low of $191.04 and a 1 year high of $288.78.
The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 15th. Stockholders of record on Friday, March 2nd will be issued a $0.34 dividend. The ex-dividend date of this dividend is Thursday, March 1st. This represents a $1.36 annualized dividend and a dividend yield of 0.51%. Teleflex’s dividend payout ratio is currently 41.59%.
A number of research firms have recently commented on TFX. ValuEngine downgraded Teleflex from a “buy” rating to a “hold” rating in a report on Wednesday, March 7th. Leerink Swann dropped their price objective on Teleflex from $321.00 to $300.00 and set an “outperform” rating on the stock in a report on Friday, February 23rd. Stephens reiterated a “buy” rating and issued a $300.00 price objective on shares of Teleflex in a report on Thursday, January 18th. Finally, Deutsche Bank cut Teleflex from a “buy” rating to a “hold” rating and set a $251.00 target price for the company. in a research report on Tuesday, November 14th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and six have given a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $281.56.
In other news, Director George Babich, Jr. sold 2,500 shares of the firm’s stock in a transaction that occurred on Tuesday, January 16th. The stock was sold at an average price of $263.38, for a total value of $658,450.00. Following the completion of the sale, the director now directly owns 10,583 shares of the company’s stock, valued at approximately $2,787,350.54. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Stephen K. M.D. Klasko sold 200 shares of the firm’s stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $248.96, for a total value of $49,792.00. Following the completion of the sale, the director now directly owns 8,080 shares of the company’s stock, valued at $2,011,596.80. The disclosure for this sale can be found here. Insiders sold a total of 11,759 shares of company stock valued at $3,089,211 over the last three months. Insiders own 2.39% of the company’s stock.
WARNING: This article was originally reported by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this article on another publication, it was illegally copied and republished in violation of US & international copyright & trademark law. The original version of this article can be viewed at https://sportsperspectives.com/2018/03/12/hpm-partners-llc-purchases-shares-of-7380-teleflex-incorporated-tfx.html.
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.